1. Volume 64, Issue 3, Pages 978-991 (September 2003)
Alpha and gamma tocopherol metabolism in healthy subjects and patients with end- stage renal disease 
Jonathan Himmelfarb, Jane Kane, Ellen Mcmonagle, Eric Zaltas, Steve Bobzin, Sekhar Boddupalli, Stephen Phinney, Guy Miller 
Kidney International 
Volume 64, Issue 3, Pages (September 2003)
DOI: /j x
Copyright © 2003 International Society of Nephrology Terms and Conditions

2. Figure 1
Structures of alpha, beta, gamma, and delta tocopherols and alpha, beta, gamma, and delta carboxyethyl-hydroxychromans (CEHCs).
Kidney International  , DOI: ( /j x)
Copyright © 2003 International Society of Nephrology Terms and Conditions

3. Figure 2
Serum alpha and gamma tocopherol (A) and alpha and gamma carboxyethyl-hydroxychroman (CEHC) (B) levels in healthy controls and hemodialysis patients after a 600mg dose of alpha tocopherol at day 0.
Kidney International  , DOI: ( /j x)
Copyright © 2003 International Society of Nephrology Terms and Conditions

4. Figure 3
Serum alpha and gamma tocopherol (A) and alpha and gamma carboxyethyl-hydroxychroman (CEHC) (B) levels in healthy controls and hemodialysis patients after a 600mg dose of gamma-enriched tocopherols at day 0.
Kidney International  , DOI: ( /j x)
Copyright © 2003 International Society of Nephrology Terms and Conditions

5. Figure 4
Serum alpha and gamma tocopherol (A) and alpha and gamma carboxyethyl-hydroxychroman (CEHC) (B) levels in healthy controls and hemodialysis patients during a 14-day course of 300mg alpha tocopherol/day.
Kidney International  , DOI: ( /j x)
Copyright © 2003 International Society of Nephrology Terms and Conditions

6. Figure 5
Serum alpha and gamma tocopherol (A) and alpha and gamma carboxyethyl-hydroxychroman (CEHC) (B) levels in healthy controls and hemodialysis patients during a 14-day course of 300mg gamma-enriched tocopherols/day.
Kidney International  , DOI: ( /j x)
Copyright © 2003 International Society of Nephrology Terms and Conditions

7. Figure 6
C-reactive protein (CRP) after 14days of (A) alpha-enriched tocopherol or (B) gamma-enriched tocopherol. Symbols are: (▪) individual patients; (□) mean of all patients.
Kidney International  , DOI: ( /j x)
Copyright © 2003 International Society of Nephrology Terms and Conditions

8. Figure 7
Interleukin-6 (IL-6) in hemodialysis patients at day 0 and day 14 of (A) alpha-enriched tocopherol or (B) gamma-enriched tocopherol. Symbols are: (▪) individual patients; (□) mean of all patients. Day 0 vs. day 14, P = 0.04.
Kidney International  , DOI: ( /j x)
Copyright © 2003 International Society of Nephrology Terms and Conditions